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Purpose: To report histopathological observations regarding one of our macular translocation 
cases.
Methods: We have performed macular translocation with 360 degree retinotomy since 1997, 
and limited macular translocation with or without subretinal membrane removal since 2002. 
One of our patients died on the ﬁ  fth postoperative day, so extensive histological examination 
of the removed neovascular membrane and entire globe was performed.
Results: We found that pigment epithelium remained attached to the neurosensory retina dur-
ing retinal separation, in which case the rotated fovea will be relocated in a partially devoided 
pigment epithelial zone. In addition, even after complete surgical removal of the membrane 
during macular translocation, large membrane remnants are still detectable by histological 
examination.
Conclusion: In our opinion, macular translocation is not a satisfactory management of sub-
foveal neovascular membranes, because of changes in the pigment epithelium during surgery, 
and large subretinal neovascular membrane remnants.
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Introduction
Subfoveal choroidal neovascularization (CNV) is a common cause of visual loss in 
patients with age-related macular degeneration (AMD), and several other disorders. 
Macular degeneration is the leading cause of blindness in the older population, and it is 
becoming more and more prevalent (Machmer 1998). At present there is no treatment 
for dry type of macular degeneration; for treatment of the wet form several medical 
and surgical therapies have been introduced with better and better results (MPSG 
1991, 1993; Ulbig et al 1993).
Photodynamic therapy with verteporﬁ  n had a signiﬁ  cant treatment beneﬁ  t in 
predominantly classic CNV (TAP Study Group 1999), and new drugs are en-route. 
The treatment of AMD associated with CNV is changing fundamentally with the 
introduction of pharmacologic interventions. Large prospective clinical trials have 
demonstrated that selective inhibition of vascular endothelial growth factor (VEGF) 
may effectively counteract the permeability and proliferative effects of this important 
stimulus of neovascular AMD. VEGF has been identiﬁ  ed as one of the major trigger-
ing elements in the pathogenesis of CNV. It is released because of hypoxia, oxidative 
tissue damage, and inﬂ  ammatory conditions and induces vascular barrier breakdown 
with leakage and proliferation of endothelial cells and neovascular growth.
Surgical removal of the subretinal membrane has been attempted, but although the 
technique seemed promising, in many cases visual acuity did not improve. Machemer Clinical Ophthalmology 2008:2(2) 448
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and Steinhorst (1993) have proposed another technique 
where after surgical removal of the subretinal membrane 
the fovea is translocated to an area with healthier pigment 
epithelium, Bruch’s membrane, and choroid. Variants have 
been described, such as detachment of only the temporal 
part of the retina, or a retinal detachment was created in the 
temporal side through the sclera without retinotomy.
Methods
We analyzed the ﬁ  xed tissue, taken at operation from one case 
in the Ophthalmic Pathology Laboratory of the Semmelweis 
University, Department of Ophthalmology, in which we 
performed a macular translocation using the Machemer and 
Steinhorst technique, with some modiﬁ  cations from Eckardt 
(Eckardt and Eckardt 1999, 2002; Eong et al 2001; Pertile and 
Claes 2002; Eckardt et al 2004), and from our own experi-
ence. We attempted to remove the entire membrane, which 
was ﬁ  xed in 10% neutral buffered formalin and processed for 
routine microscope examination. After surgery we usually see 
a retinal fold starting from the optic disc and extending to the 
periphery, but this fold usually disappears after 5–7 days.
Our patient died (from intracranial hemorrhage) on the 
ﬁ  fth day after surgery, and it was possible to perform histo-
logical examination on the operated eye.
At gross examination, we found that rotation had been 
achieved through an angle of 25–30 degrees. The next step 
was to perform sections of the translocated macula in the 
region of former subretinal membrane, as well as in the 
excised membrane, and our ﬁ  ndings are discussed below.
Results
Extensive histological examination of the post-mortem 
enucleated globe revealed that the macula was relocated 
upwards by about 30 degrees to a place where no choroidal 
neovascular membrane was present.
We are able to show that, even after surgical removal of 
the membrane during macular translocation with 360-degree 
retinotomy, subretinal neovascular membrane remnants with 
thick-walled and dilated vessels can be seen. There are still some 
retinal pigment epithelial (RPE) cells attached to the residual 
membrane. The overlying retina shows only one row of ganglion 
cells, which indicates that this is not the macular area.
The retinal pigment epithelium has partly remained 
attached to the rotated retina. At higher magniﬁ  cation migra-
tion of the RPE cells towards the retina can be observed 
(Figure 1).
Tears in the RPE are present, which are more frequently 
detected in disciform scars. The RPE layer ends abruptly. The 
components of the disciform scar in the Bruch’s membrane 
and subretinal area have become continuous. A vessel from 
the subretinal neovascular membrane can be seen extending 
into the subretinal space.
As we expected we found a thickened Bruch’s mem-
brane, few points of calciﬁ  cation, some remnants from the 
surgically removed subretinal membrane underneath and 
above the pigment epithelium (Bereczki et al 2000) as well 
as choriocapillary atrophy.
The outer retina seems not to be affected at the time of 
surgery.
From our point of view, it was of interest to examine 
the attachment of the pigment epithelium to the retina or 
Bruch’s membrane along the temporary postoperative 
retinal fold. We found that the pigment epithelium was 
attached to the retina and Bruch’s membrane (Bereczki et al 
2000) (Figure 2) and we were able to follow this from the 
optic disc through the macular region up to the temporal 
periphery.
Even at the site of one of our retinotomies, which was per-
formed in the line of retinal fold, we found the same picture. 
This can be caused by the presence of subretinal proliferation 
before surgery, or more probably provoked by surgery. This 
is supported by the wide extent of this ﬁ  nding.
Extensive histological examination of the intraoperatively 
removed subfoveal CNV membrane showed newly formed 
capillaries within a ﬁ  brotic stroma. Pigmented cells are plen-
tiful. Some of the pigmented cells are derived from the retinal 
pigment epithelium, but others stained for hemosiderin with 
a Prussian blue stain and therefore are hemosiderin-loaded 
macrophages. The membrane also contains collagen and 
mucopolysaccharide materials.
The RPE cells are located on one side of the neovascular 
membrane but they are also seen inside the same structure 
which itself is densely ﬁ  brotic and contains a myriad of new 
vessels. A fragment of Bruch’s membrane thickened by basal 
linear deposit can also be seen. It is not always possible to 
determine the exact location of the membrane (Figure 3).
Discussion
Subfoveal CNV is a common cause of visual loss in patients 
with AMD, and several other disorders. Macular degeneration 
is the leading cause of blindness in the older population, and it 
is becoming more and more prevalent. Surgical removal of this 
neovascular membrane has been proposed as an alternative 
method of treatment. Although improvement of surgical tech-
nique, diminishing numbers of surgery-linked complications 
have been observed by both our and international experiences, Clinical Ophthalmology 2008:2(2) 449
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the visual prognosis for patients with surgically excised 
membranes after macular translocation surgery is variable 
(Eckardt and Eckardt 1999, 2002; Eong et al 2001; Pertile 
and Claes 2002; Eckardt et al 2004) and we have to deal with 
an increased number of recurrences (Bereczki et al 2000; 
Abdel-Meguid et al 2003; MacLaren et al 2005).
We also know from Grossniklaus and colleagues 
(Grossniklaus and Gass 1998; Grossniklaus et al 2002) that 
different membrane types will probably have a different 
impact regarding the histopathological changes after macular 
translocation surgery.
From our point of view, it was of interest to examine the 
attachment of the pigment epithelium to the retina or Bruch’s 
membrane along the temporary postoperative retinal fold. We 
found that the pigment epithelium was mainly attached to the 
retina and not to the Bruch’s membrane. We were able to fol-
low this attachment from the optic disc through the macular 
region up to the temporal periphery. Even at the site of one 
of our retinotomies, which was performed in the line of the 
retinal fold, we found the same histological picture.
Attachment of the pigment epithelium to the retina or 
Bruch’s membrane can be caused by the presence of sub-
retinal proliferation before surgery, but probably occurred 
during surgery. This is supported by the wide extent of this 
ﬁ  nding. We do not know if these changes may occur during 
the postoperative period of ﬁ  ve days.
We know that there is no improvement in visual acuity 
in some cases after surgery, and we hypothesize that this is 
because of a signiﬁ  cant part of the pigment epithelium has 
been translocated along with the retina.
From our histological sections we see that some part of 
the membrane remains in place even after surgical “removal” 
and we could see that the remaining membrane is a mixed 
one with extensions deep into and superﬁ  cial to the pigment 
epithelium.
We tentatively believe that this may be connected with 
the fact that the pigment epithelium remained attached to the 
retina. In a type 1 subretinal membrane situated only above 
the pigment epithelium, this would not occur.
More research is needed to discover if there is any connec-
tion between the type of membrane, related to the condition 
of the pigment epithelium, and the apparent stronger adhesion 
between the pigment epithelium and retina (or relatively 
weaker adhesion to Bruch’s membrane), but in our opinion 
Figure 2 Pigment cells attached to Bruch’s membrane, which is rather damaged. 
Hematoxylin and eosin, original magniﬁ  cation ×16.
Figure 3 Subfoveal choroidal neovascular membrane. Hematoxylin and eosin, original 
magniﬁ  cation ×16.
Figure 1 Migration of the RPE cells towards the retina, the photoreceptor layer 
is disorganized, and there is an RPE detachment. Hematoxylin and eosin, original 
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macular translocation can not be a satisfactory management 
of subfoveal chorioidal neovascular membrane.
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